Early Phase Cancer Immunotherapy / Current Cancer Research (PDF)

Name: Early Phase Cancer Immunotherapy / Current Cancer Research
Brand: Springer-Verlag GmbH
SKU: 102838086
Price: 153.99 EUR
Availability: OnlineOnly

(Sprache: Englisch)

Schreiben Sie einen Kommentar zu "Early Phase Cancer Immunotherapy / Current Cancer Research".

Merken

Mehr zum Inhalt Autorenporträt Video

eBook (pdf) 153.99 €

Buch (Gebunden) 164.99 €

Leider schon ausverkauft

Bestellnummer: 102838086

Printausgabe 164.99 €

eBook (pdf) -7% 153.99 €

Download bestellen

Verschenken

Lastschrift, Kreditkarte, Paypal, Rechnung
Kostenloser tolino webreader

Produktdetails

Produktbeschreibung
Autorenporträt
eBook Hilfe
Biblio. Angaben / Produktdetails

Produktinformationen zu „Early Phase Cancer Immunotherapy / Current Cancer Research (PDF)“

This volume, a state-of-the-art review of early phase clinical trials for cancer immunotherapy, discusses biomarker selection, combinatorial strategies and their safety or toxicity, determination of Phase 2 dosing, endpoints in the setting of radiographic pseudoprogression, histology selection, and novel immunotherapeutics as they relate to early phase cancer immunotherapy.

Autoren-Porträt

Razelle Kurzrock, MD, is Senior Deputy Director for Clinical Science, Chief, Division of Hematology & Oncology, Murray Professor of Medicine, Director, Center for Personalized Cancer Therapy & Clinical Trials Office, University of California, San Diego.

Sandip Patel, MD, is Assistant Professor, Cancer Immunotherapy Program, Experimental Therapeutics (Phase 1 Program), Thoracic Oncology, Division of Hematology & Oncology and Center for Personalized Cancer Therapy, UC San Diego Moores Cancer Center.